You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 161 No. 9, May 14, 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Commentary
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Randomized Controlled Trial
 •Hypertension
 •Alert me on articles by topic

Is It Time for a New Approach to the Initial Treatment of Hypertension?

Marvin Moser, MD

Arch Intern Med. 2001;161:1140-1144.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

RESULTS OF recent trials in the management of hypertension indicate that an update of recommendations for initial therapy may be indicated.1-9

In 1997, the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-VI)10 recommended that diuretics or ß-blockers be chosen as initial therapy if lifestyle modifications failed to reduce blood pressure to goal levels, unless there were specific or compelling reasons to use other drugs. At that time, the decision was based on the fact that, other than 1 or 2 studies, all of the placebo-controlled morbidity and mortality outcome clinical trials had used diuretics or ß-blockers as initial treatment. Results had been impressive, with a decrease of 38% in strokes, 16% in coronary heart disease events, and more than 40% in the occurrence of heart failure.11-12 One trial, the Systolic Hypertension Europe (Syst-Eur) trial, had used nitrendipine, . . . [Full Text of this Article]

TRIALS WITH LITTLE APPARENT DIFFERENCE IN OUTCOME REGARDLESS OF THERAPY


TRIALS WITH NO OVERALL DIFFERENCE IN OUTCOME BUT SOME DIFFERENCES BETWEEN DRUGS

TRIALS IN WHICH SPECIFIC MEDICATIONS IMPROVED OUTCOME MORE THAN OTHERS

THE CCB DEBATE

WHAT TREATMENT SHOULD BE RECOMMENDED NOW?

SHOULD RECOMMENDATIONS BE CHANGED?

HOW DO CCBs, ACEIs, AND ANGIOTENSIN RECEPTOR BLOCKERS FIT IN THE TREATMENT ALGORITHM?
13 Murray Hill Rd
Scarsdale, NY 10583



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Translating Research into Practice: Are Physicians Following Evidence-Based Guidelines in the Treatment of Hypertension?
Holmes et al.
Med Care Res Rev 2004;61:453-473.
ABSTRACT  

Time Trends in High Blood Pressure Control and the Use of Antihypertensive Medications in Older Adults: The Cardiovascular Health Study
Psaty et al.
Arch Intern Med 2002;162:2325-2332.
ABSTRACT | FULL TEXT  

Focus: Hypertension in the Aged Population
Futterman and Lemberg
Am J Crit Care 2002;11:80-86.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.